HomeIntroductionOverview of
the consortium
Report &
 Guide Book for Health-Care Providers
Back to Table of Contents


  1. Haspels AA. Emergency Contraception : a review. Contraception 1994; 50 : 101-108.
  2. Trussell J, Ellertson C, Stewart F. The effectiveness of the Yuzpe regimen of postcoital contraception. Family
    Planning Perspectives 1996; 28(2) : 58-64.
  3. Landgren BM, Johannisson E, Aedo AR, Kumar A, Yong-en S. The effect of levonorgestrel administered in large
    doses at different stages of the cycle on ovarian function and endometrial morphology. Contraception 1989; 39(3):
  4. Lippes J, Malik T and Tatum HJ. The post-coital copperT. Adv Plann Parenth 1976; 11 : 24-29.
  5. Ho PC, Kwan MS. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in postcoital
    contraception. Human Reproduction 1993; 8 : 389-92.
  6. Task Force on Postovulatory Methods of Fertility Regulation. Randomized controlled trial of levonorgestrel versus
    the Yuzpe regimen of combined oral contraceptives for emergency contraception. The Lancet 1998; 352 : 428-433.
  7. Task Force on postovulatory methods of fertility regulation. Comparison of three single doses of mifepristone as
    emergency contraception: a randomized trial. Lancet. 1999; 353: 697-702.
  8. International Institute of Population Sciences. Family Planning and Contraceptive use. National Family Health
    Survey (NFHS-1) 1995-96.
  9. Chhabra R, Nuna S, Abortion in India : An Overview. New Delhi; Veerandra Publishers 1993.
    International Institute of Population Sciences. Family Planning and Contraceptive use. National Family Health
    Survey (NFHS-2) 1998-99; 129-144.
  10. Von Hertzen H et al Low dose mifepristone and two regimens of Levonorgestrel for emergency contraception : a
    WHO multicentre randomised trial. The Lancet, 2002; 360 : 1803-1810.
  11. Webb AMC, Russell J, Elstein M. Comparison of the Yuzpe regimen, danazol and mifepristone (RU 486) in oral
    postcoital contraception. BMJ 1992; 305 : 927-31.
  12. Zuliani G, Colombo UF, Molla R. Hormonal postcoital contraception with an ethinylestradiol-norgestrel combination
    and two danazol regimens. Eur J Obstet Gynecol Reprod Biol 1990; 37 : 253-60.
  13. Wilcox AJ, Weinberg CR, Baird DD. Timing of sexual intercourse in relation to ovulation. Effects on the probability
    of conception, survival of the pregnancy, and sex of the baby. N. Engl J Med 1995, 333: 1517-21.
  14. GATHER Guide to counseling. Population Reports Series J, No. 48, Feb 2000.
  15. Medical Eligibility Criteria for Contraceptive Use. 2nd edition. Reproductive Health and Research. World Health
    Organization, Geneva
  16. Trussell J. Contraceptive efficacy. In : Hatcher RA, Trussell J, Stewart F, Cates W, Steward GK, Guest F, Kowal D.
    Contraceptive Technology. 17th edition. New York : Ardent Media Inc., 1998.
  17. Bracken MB. Oral contraceptives and congenital malformations in offspring : a review and meta-analysis of the
    prospective studies. Obstetrics & Gynaecology 1990; 76 : 552-557.
  18. Mc Cann MF, Potter LS. Progestin-only oral contraception : A comprehensive review. Contraception 1994; 50 (6
    Suppl 1) S1 – S195.
  19. Baulieu EE. Contragestion and other clinical applications of RU 486, an anti progesterone at the receptor. Science
    1989; 245 : 1351.

Back to Top   |   Back to Table of Contents

Introduction | Overview of the Consortium | Consensus Statements
Report & Recommendations | Future Guidelines | Training Manual
 For more information contact ec_india@hotmail.com | Credits